Aman M. G. et al. (2014)
A review of atomoxetine effects in young people with developmental disabilities.
Research in Developmental Disabilities
June, 35(6), pp. 1412-1424.
Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.
Journal of Autism and Developmental Disorders
33(4), pp. 449-454
Pediatrics
January, 125 S 1-18
A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms.
Journal of the American Academy of Child and Adolescent Psychiatry
47(6), pp. 642-651
Handen B. L. et al. (2015)
Journal of the American Academy of Child and Adolescent Psychiatry
November, 54(11), pp. 905-915.
Hyman S. L. , Levy S. E. (2005)
Introduction: novel therapies in developmental disabilities - hope, reason, and evidence.
Mental Retardation and Developmental Disabilities Research Reviews
11(2), pp. 107-109
Hyman S. L. et al. (2016)
The gluten-free, casein-free diet: a double-blind challenge trial in children with autism.
Journal of Autism and Developmental Disorders
January, 46(1), pp. 205-220.
Levy S. E. , Hyman S. L. (2008)
Complementary and alternative medicine treatments for children with autism spectrum disorders.
Child and Adolescent Psychiatric Clinics of North America
17(4), pp. 803-820
Levy S. E. , Hyman S. L. (2005)
Novel treatments for autistic spectrum disorders.
Mental Retardation and Developmental Disabilities Research Reviews
11(2), pp. 131-142
Malone R. P. et al. (2007)
Ziprasidone in adolescents with autism: an open-label pilot study.
Journal of Child and Adolescent Psychopharmacology
17(6), pp. 779-790
Perrin J. M. et al. (2012)
Complementary and alternative medicine use in a large pediatric autism sample.
Pediatrics
130 S77-82.
Journal of the Canadian Academy of Child and Adolescent Psychiatry
October, 55(10),
Showing 1 to 15 of 15 Results